Risk Factors for Neuroendocrine Neoplasms

Not yet recruitingOBSERVATIONAL

Enrollment

14,250

Participants

Timeline

Start Date

May 15, 2025

Primary Completion Date

August 31, 2025

Study Completion Date

August 31, 2026

Conditions

Neuroendocrine Neoplasm of LungNeuroendocrine Neoplasm of Gastrointestinal Tract (Disorder)

Interventions

OTHER

Case-control study (no intervention)

Observation of risk factors in cases and controls

All Listed Sponsors

collaborator

Bavarian Association of Statutory Health Insurance Accredited Physicians

UNKNOWN

lead

Bavarian Cancer Registry

OTHER_GOV

NCT06282016 - Risk Factors for Neuroendocrine Neoplasms | Biotech Hunter | Biotech Hunter